Your monthly digest of professional document developments.

The main objective of the Airway Management SIG is the promotion of science, education, exchange and distribution of ideas between anaesthetists with a particular interest and involvement in airway management.

The board has approved a new position statement on the use of ketamine in the management of chronic non-cancer pain

Important information on changes to the design of salbutamol (Ventolin) metered dose inhalers (MDIs/‘puffers’) in Australia.

Changes to item mapping in the MBS affecting both pain medicine and anaesthesia will come into effect on 1 March 2022.

Safety alerts; ACSQHC Antimicrobial Stewardship Clinical Care Standard; webAIRS sessions at the 2021 ANZCA ASM

Our Effective Management of Anaesthetic Crises (EMAC) Course Sub-committee is looking for two new members. Applications close Friday 30 April 2021.

ANZCA has published a joint statement with diabetes groups in Australia and NZ on periprocedural diabetic ketoacidosis and SGLT2i use.

The college has provided a 2022 election priorities statement to the major political parties.

FPM has written to Australian health officials seeking an urgent response to concerns about imminent MBS changes